首页> 外国专利> compound or a salt thereof, prodrug, drug, fatty acid amide hydrolase inhibitor, use of the compound or prodrug, fatty acid amide hydrolase inhibition methods in a mammal, brain cell protection and / or neural cells in a mammal to prevent or treat cerebrovascular disorders, head injury or spinal cord damage in a mammal, to prevent or treat disease, to protect brain cells and / or neural cells in a mammal, of Measuring a Fatty Acid Amide Hydrolase Activity and Preventing or Treating Sleep Disorders in a Mammal, Brain-Neuroprotective and Therapeutic or Prophylactic Agents, Kit, and Process for Producing a Compound

compound or a salt thereof, prodrug, drug, fatty acid amide hydrolase inhibitor, use of the compound or prodrug, fatty acid amide hydrolase inhibition methods in a mammal, brain cell protection and / or neural cells in a mammal to prevent or treat cerebrovascular disorders, head injury or spinal cord damage in a mammal, to prevent or treat disease, to protect brain cells and / or neural cells in a mammal, of Measuring a Fatty Acid Amide Hydrolase Activity and Preventing or Treating Sleep Disorders in a Mammal, Brain-Neuroprotective and Therapeutic or Prophylactic Agents, Kit, and Process for Producing a Compound

机译:化合物或其盐,前药,药物,脂肪酸酰胺水解酶抑制剂,在哺乳动物中使用该化合物或前药,脂肪酸酰胺水解酶抑制方法,在哺乳动物中保护脑细胞和/或神经细胞以预防或治疗脑血管疾病,以预防或治疗哺乳动物的疾病,保护哺乳动物的脑细胞和/或神经细胞,预防或治疗疾病,保护脂肪酸酰胺水解酶的活性并预防或治疗哺乳动物的脑部睡眠障碍-神经保护和治疗或预防剂,试剂盒和生产化合物的方法

摘要

COMPOUND OR A SALT OF THE SAME, PRODUCT, MEDICINAL PRODUCT, FATTY ACID AMIDE HYDROLASE INHIBITOR, USE OF COMPOUND OR PRODUCT, FATTY ACID AMIDE HYDROLASE METHODS, IN A PROPHYAL CULA MAMMIFER, AND / OR NEURAL CELLS IN A MAMMALIAN, FOR PREVENTION OR TREATMENT OF CEREVOVASCULAR DISORDERS, HEAD INJURY OR SPINAL CORD DAMAGE, FOR PREVENTION OR TREATMENT OF CELL AND NEEDLE / CELL IN THE CELL MEASUREMENT OF A FATTY ACID AMIDE HYDROLASE ACTIVITY OR A FATTY ACID AMIDE HYDROLASE ACTIVITY AND PREDICTION OR TREATMENT OF SLEEP DISORDERS IN A MAMMALIAN, PROTEPHERE, PROTECT, AND NEUTROPROETE PROTETETIC, BRAIN NEUROLASE ACTIVITY TO PRODUCE A COMPOUND. A FAAH inhibitor, and a preventive / therapeutic agent for cerebrovascular disorders and a preventive / therapeutic agent for sleep disorders, each containing the inhibitor. The FAAH inhibitor is a compound represented by the formula (I-O ~ '): (wherein Z represents oxygen or sulfur; R¬1¬ represents optionally substituted aryl or an optionally substituted heterocyclic group; R¬1a¬ represents h, or an optionally substituted hydrocarbon group, hydroxy, etc. R 1 represents optionally substituted piperidine-1,4-diyl or optionally substituted piperazine-1,4-diyl R 3 represents an optionally substituted group formed by removal of two atoms of a 5-membered aromatic heterocycle having from 1 to 3 heteroatoms selected from nitrogen, oxygen, and sulfur, or represents -CO-, etc., and R¬ 4¬ represents an optionally substituted hydrocarbon group or optionally substituted heterocyclic group) or a salt of the compound.
机译:预防,预防或治疗哺乳动物,哺乳类食物中相同,产品,医药产品,脂肪酸酰胺水解酶抑制剂,化合物或产品,脂肪酸酰胺水解酶方法的使用或化合物颈动脉疾病,头部损伤或脊髓损伤,以预防或治疗脂肪酸酰胺水解酶活性或脂肪酸酰胺水解酶活性和老年痴呆症的细胞测量中的细胞和针/细胞蛋白质,蛋白质和中性蛋白质的蛋白质,脑神经酶活性,可以生产化合物。 FAAH抑制剂,脑血管疾病的预防/治疗剂和睡眠障碍的预防/治疗剂,每种均含有该抑制剂。 FAAH抑制剂是由式(IO〜')表示的化合物:(其中Z代表氧或硫; R 1代表任选取代的芳基或任选取代的杂环基; R 1a代表h或任选取代的R 1表示任选取代的哌啶-1,4-二基或任选取代的哌嗪-1,4-二基R 3表示通过除去5元芳族杂环的两个原子形成的任选取代的基团。 1至3个选自氮,氧和硫的杂原子,或代表-CO-等,R 4代表任选取代的烃基或任选取代的杂环基)或化合物的盐。

著录项

  • 公开/公告号BRPI0517753A

    专利类型

  • 公开/公告日2008-10-21

    原文格式PDF

  • 申请/专利权人 TAKEDA PHARMACEUTICAL COMPANY LIMITED;

    申请/专利号BR2005PI17753

  • 申请日2005-11-17

  • 分类号C07D261/20;A61K31/422;A61K31/4245;A61K31/427;A61K31/433;A61K31/4439;A61K31/454;A61K31/4709;A61K31/4725;A61K31/496;A61K31/497;A61K31/501;A61K31/5025;A61K31/506;A61K31/5377;A61K45;A61P25/20;A61P25/28;C07D277/20;C07D277/42;

  • 国家 BR

  • 入库时间 2022-08-21 20:08:43

相似文献

  • 专利
  • 外文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号